10x Genomics (NASDAQ:TXG) Research Coverage Started at Wolfe Research

Wolfe Research assumed coverage on shares of 10x Genomics (NASDAQ:TXG – Free Report) in a research note released on Wednesday, Marketbeat Ratings reports. The firm issued an outperform rating and a $55.00 target price on the stock. A number of other equities analysts also recently commented on the stock. Bank of America raised shares of […]

Leave a Reply

Your email address will not be published.

Previous post Pivotal Research Increases Comcast (NASDAQ:CMCSA) Price Target to $58.00
Next post Barclays Boosts PulteGroup (NYSE:PHM) Price Target to $120.00